ABBVIE INC. vs. Tonix Pharmaceuticals Holding Corp.
ABBVIE INC. (ABBV) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| ABBV | TNXP | |
|---|---|---|
| Market Cap | $469.63 billion | $138.41 million |
| Revenue (TTM) | — | $29.10 million |
| Net Income (TTM) | — | $-159,666,000 |
ABBV leads on 1 of 1 size & scale factors.
Valuation
| ABBV | TNXP | |
|---|---|---|
| Price / Book | — | 0.62 |
| Price / Sales | — | 4.76 |
ABBV and TNXP split the valuation factors evenly.
Profitability
| ABBV | TNXP | |
|---|---|---|
| Net Margin | — | -548.64% |
| Return on Equity | — | -71.83% |
ABBV and TNXP split the profitability factors evenly.
Dividend
| ABBV | TNXP | |
|---|---|---|
| Dividend Yield | 2.60% | — |
ABBV and TNXP split the dividend factors evenly.
Risk & Sentiment
| ABBV | TNXP | |
|---|---|---|
| Short Interest | 0.85% | 1.64% |
ABBV leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, TNXP overview, TNXP financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.